Different patterns of NT-proBNP secretion in acute coronary syndromes

被引:3
|
作者
Ferraro, Simona [1 ]
Lupi, Alessandro [1 ]
Marano, Giuseppe [2 ]
Rossi, Lidia [1 ]
Ciardi, Laura [3 ]
Vendrarnin, Chiara [3 ]
Bellorno, Giorgio [3 ]
Boracchi, Patrizia [2 ]
Bongo, Angelo Sante [1 ]
Biganzoli, Elia [2 ]
机构
[1] SCDO Cardiol, Osped Maggiore, Novara, Italy
[2] Univ Milan, Ist Stat Med & Biometria, I-20122 Milan, Italy
[3] SCDU Lab Ric Chim Clin, Osped Maggiore, Novara, Italy
关键词
Natriuretic peptides; Acute coronary syndrome; Secretory pattern; Kinetic; BRAIN NATRIURETIC PEPTIDE; PLASMA CHROMOGRANIN-A; MYOCARDIAL-INFARCTION; RISK STRATIFICATION; RENAL-FUNCTION; CYSTATIN-C; MARKER; EXPRESSION; MORTALITY; SYMPTOMS;
D O I
10.1016/j.cca.2009.01.005
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: The wide variability of NT-proBNP levels in acute coronary syndromes could arise from sympathetic activation and glomerular impairment. The aim of the study was to investigate, in this setting, the dependence of NT-proBNP from Chromogranin A (CgA) and Cystatin C (CC) levels, respectively assessing sympathetic activation and glomerular impairment. Methods: In 132 patients, 90 ST elevation acute coronary syndrome (STE-ACS) and 42 non ST elevation acute coronary syndrome (NSTE-ACS), within 24 h from symptoms and with creatinine levels lower than 141.4 mu mol/L, we measured NT-proBNP, CgA and CC levels. In 41 STE-ACS patients we evaluated the kinetic profiles of the markers. Results: From the multiple regression model, to investigate the dependence of NT-proBNP from CgA, CC levels, time from symptom STE-ACS/NSTE-ACS subsets, gender, adjusting for the effect of left ventricular ejection fraction and age we had evidence of. 1) interactions involving the subsets, the first with CgA levels and the second with age; 2) non linear increasing effect of the delay on NT-proBNP secretion. Conclusions: Our data showed that, in the population studied, sympathetic activation and age could affect NT-proBNP secretion yielding different secretory patterns in STE- or NSTE-ACS. Only for STE-ACS we observed higher marker secretion in older patients. (c) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:176 / 181
页数:6
相关论文
共 50 条
  • [21] Associations of osteopontin and NT-proBNP with circulating miRNA levels in acute coronary syndrome
    Kwee, Lydia Coulter
    Neely, Megan L.
    Grass, Elizabeth
    Gregory, Simon G.
    Roe, Matthew T.
    Ohman, E. Magnus
    Fox, Keith A. A.
    White, Harvey D.
    Armstrong, Paul W.
    Bowsman, Lenden M.
    Haas, Joseph, V
    Duffin, Kevin L.
    Chan, Mark Y.
    Shah, Svati H.
    PHYSIOLOGICAL GENOMICS, 2019, 51 (10) : 506 - 515
  • [22] Release pattern of N-terminal pro B-type natriuretic peptide (NT-proBNP) in acute coronary syndromes
    Weber, M
    Kleine, C
    Keil, E
    Rau, M
    Berkowitsch, A
    Elsaesser, A
    Mitrovic, V
    Hamm, C
    CLINICAL RESEARCH IN CARDIOLOGY, 2006, 95 (05) : 270 - 280
  • [23] Peculiarities of Dynamics and Prognostic Value of NT-proBNP Level in Different Variants of Treatment of Patients With Acute Coronary Syndrome
    Shreider, E. V.
    Shakhnovitch, R. M.
    Bosykh, E. G.
    Ruda, M. Ya.
    KARDIOLOGIYA, 2010, 50 (02) : 15 - 20
  • [24] BNP or NT-proBNP?
    不详
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (10) : A104 - A104
  • [25] NT-proBNP as a predictor of calcified coronary atherosclerosis progression
    Pastormerlo, L. E.
    Maffei, S.
    Della Latta, D.
    Chubuchny, V.
    Giampietro, C.
    Susini, C.
    Berti, S.
    Passino, C.
    Emdin, M.
    Chiappino, D.
    EUROPEAN HEART JOURNAL, 2015, 36 : 1140 - 1141
  • [26] NT-proBNP and exercise
    Chatha, Kamaljit
    Alsoud, Mahrous
    Griffiths, Melanie J.
    Elfatih, Abubaker
    Horton, Richard C.
    Dunmore, Simon J.
    Gama, Rousseau
    ANNALS OF CLINICAL BIOCHEMISTRY, 2006, 43 : 240 - 240
  • [27] Cross-reactivity studies of BNP, proBNP, and NT-proBNP in commercial NT-proBNP assays
    Apple, F. S.
    Luckenbill, K. N.
    Jaffe, A. S.
    Mair, J.
    Ordonez-Llanos, J.
    Wu, A. H.
    Pagani, F.
    Tate, J.
    Saenger, A.
    Christenson, R. H.
    Ler, R.
    Murakami, M. M.
    CLINICAL CHEMISTRY, 2008, 54 (06) : A84 - A84
  • [28] Preliminary crossreactivity studies of proBNP, BNP and NT-proBNP in commercial BNP and NT-proBNP assays
    Apple, F. S.
    Luckenbill, K.
    Ler, R.
    Murakami, M. M.
    Christenson, R.
    Jaffe, A.
    Mair, J.
    Ordonez-Llanoss, J.
    Pagani, F.
    Tate, J.
    Wu, A.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A6 - A7
  • [29] Baseline inflammatory markers, NT-proBNP and LVEF predict heart failure and cardiac death one year after acute coronary syndromes
    Denegri, A.
    Rossi, V. A.
    Niederseer, D.
    Obeid, S.
    Klingenberg, R.
    Raeber, L.
    Gencer, B.
    Mach, F.
    Rodondi, N.
    Heg, D.
    Windecker, S.
    Ruschitzka, F.
    Luescher, T. F.
    Matter, C.
    EUROPEAN HEART JOURNAL, 2018, 39 : 478 - 479
  • [30] SERIAL MEASUREMENT OF NT-PROBNP AND HS-CRP AFTER ACUTE CORONARY SYNDROMES COULD IDENTIFY PATIENTS WITH HIGHER RESIDUAL RISK
    Ayton, Sarah
    Michail, Olga
    Bhatti, Maria
    Gollop, Nicholas D.
    Ryding, Alisdair
    Tang, Jonathan
    Washbourne, Christopher
    Nunney, Ian
    Flather, Marcus
    HEART, 2018, 104 : A6 - A7